Navigating 4 Analyst Ratings For Pediatrix Medical Group
Portfolio Pulse from Benzinga Insights
In the past three months, four analysts have provided ratings for Pediatrix Medical Group (NYSE:MD), all of which are indifferent. The average 12-month price target has decreased by 6.13% to $9.5. Analysts from Truist Securities, Jefferies, and Mizuho have maintained or lowered their ratings and price targets.
May 15, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Analysts have shown indifference towards Pediatrix Medical Group (NYSE:MD) with a 6.13% decrease in the average 12-month price target to $9.5. Analysts from Truist Securities, Jefferies, and Mizuho have maintained or lowered their ratings and price targets.
The unanimous indifference from analysts and the decrease in the average price target suggest a lack of confidence in Pediatrix Medical Group's short-term performance. This could lead to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100